ProstaGene's Acquisition

ProstaGene was acquired by CytoDyn on July 12, 2018.

ProstaGene is a biotechnology start up company that integrates proprietary molecular diagnostics with novel therapeutic screening and commercial experience in order to develop novel treatments for can…

Articles about ProstaGene's Acquisition: